These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 33467190)

  • 21. Immunogenicity and Induction of Functional Antibodies in Rabbits Immunized with a Trivalent Typhoid-Invasive Nontyphoidal
    Baliban SM; Allen JC; Curtis B; Amin MN; Lees A; Rao RN; Naidu G; Venkatesan R; Rao DY; Mohan VK; Ella KM; Levine MM; Simon R
    Molecules; 2018 Jul; 23(7):. PubMed ID: 30018230
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Emergence and serovar profiling of non-typhoidal Salmonellae (NTS) isolated from gastroenteritis cases-A study from South India.
    Ballal M; Devadas SM; Shetty V; Bangera SR; Ramamurthy T; Sarkar A
    Infect Dis (Lond); 2016; 48(11-12):847-51. PubMed ID: 27300440
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Attenuated
    Troxell B; Mendoza M; Ali R; Koci M; Hassan H
    Vaccines (Basel); 2020 Nov; 8(4):. PubMed ID: 33153043
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of a highly attenuated Salmonella enterica serovar Typhimurium mutant strain.
    Tang IK; Ji DD; Chou CF; Lin HC; Liao CL; Sytwu HK; Wang JJ; Liu YT
    J Microbiol Immunol Infect; 2002 Dec; 35(4):229-35. PubMed ID: 12542248
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Live oral typhoid vaccine Salmonella Typhi Ty21a - a surrogate vaccine against non-typhoid salmonella?
    Kantele A; Pakkanen SH; Siitonen A; Karttunen R; Kantele JM
    Vaccine; 2012 Nov; 30(50):7238-45. PubMed ID: 23084770
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Salmonella Typhi outer membrane protein STIV is a potential candidate for vaccine development against typhoid and paratyphoid fever.
    Das S; Chowdhury R; Pal A; Okamoto K; Das S
    Immunobiology; 2019 May; 224(3):371-382. PubMed ID: 30952553
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Live-attenuated Salmonella enterica serotype Choleraesuis vaccine with regulated delayed fur mutation confer protection against Streptococcus suis in mice.
    Li YA; Chen Y; Du YZ; Guo W; Chu D; Fan J; Wang X; Bellefleur M; Wang S; Shi H
    BMC Vet Res; 2020 May; 16(1):129. PubMed ID: 32381017
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of the Salmonella enterica Serovar Pullorum Pathogenicity Island 2 Mutant as a Candidate Live Attenuated Oral Vaccine.
    Yin J; Cheng Z; Wang X; Xu L; Li Q; Geng S; Jiao X
    Clin Vaccine Immunol; 2015 Jul; 22(7):706-10. PubMed ID: 25924763
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oral vaccination of BALB/c mice with Salmonella enterica serovar Typhimurium expressing Pseudomonas aeruginosa O antigen promotes increased survival in an acute fatal pneumonia model.
    DiGiandomenico A; Rao J; Goldberg JB
    Infect Immun; 2004 Dec; 72(12):7012-21. PubMed ID: 15557624
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Non-typhoidal Salmonella serovars associated with invasive and non-invasive disease in the Lao People's Democratic Republic.
    Le Thi Phuong T; Rattanavong S; Vongsouvath M; Davong V; Phu Huong Lan N; Campbell JI; Darton TC; Thwaites GE; Newton PN; Dance DAB; Baker S
    Trans R Soc Trop Med Hyg; 2017 Sep; 111(9):418-424. PubMed ID: 29342283
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antibody responses against flagellin in mice orally immunized with attenuated Salmonella vaccine strains.
    De Almeida ME; Newton SM; Ferreira LC
    Arch Microbiol; 1999 Aug; 172(2):102-8. PubMed ID: 10415171
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Design of glycoconjugate vaccines against invasive African Salmonella enterica serovar Typhimurium.
    Rondini S; Micoli F; Lanzilao L; Gavini M; Alfini R; Brandt C; Clare S; Mastroeni P; Saul A; MacLennan CA
    Infect Immun; 2015 Mar; 83(3):996-1007. PubMed ID: 25547792
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Safety and tolerability of a live oral Salmonella typhimurium vaccine candidate in SIV-infected nonhuman primates.
    Ault A; Tennant SM; Gorres JP; Eckhaus M; Sandler NG; Roque A; Livio S; Bao S; Foulds KE; Kao SF; Roederer M; Schmidlein P; Boyd MA; Pasetti MF; Douek DC; Estes JD; Nabel GJ; Levine MM; Rao SS
    Vaccine; 2013 Dec; 31(49):5879-88. PubMed ID: 24099872
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Functional Activity of Antibodies Directed towards Flagellin Proteins of Non-Typhoidal Salmonella.
    Ramachandran G; Tennant SM; Boyd MA; Wang JY; Tulapurkar ME; Pasetti MF; Levine MM; Simon R
    PLoS One; 2016; 11(3):e0151875. PubMed ID: 26998925
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regulated Delayed
    Su H; Liu Q; Wang S; Curtiss R; Kong Q
    Theranostics; 2019; 9(12):3565-3579. PubMed ID: 31281498
    [No Abstract]   [Full Text] [Related]  

  • 36. Genetic detoxification of an aroA Salmonella enterica serovar Typhimurium vaccine strain does not compromise protection against virulent Salmonella and enhances the immune responses towards a protective malarial antigen.
    McKelvie ND; Khan SA; Karavolos MH; Bulmer DM; Lee JJ; DeMarco R; Maskell DJ; Zavala F; Hormaeche CE; Khan CM
    FEMS Immunol Med Microbiol; 2008 Mar; 52(2):237-46. PubMed ID: 18177343
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Salmonella enterica serovar-specific transcriptional reprogramming of infected cells.
    Hannemann S; Galán JE
    PLoS Pathog; 2017 Jul; 13(7):e1006532. PubMed ID: 28742135
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Experimental salmonellosis challenge model in older calves.
    Snider TA; Gull T; Jackson TA; Martinez-Becerra FJ; Picking DR; Picking WD; Picking WL
    Vet Microbiol; 2014 May; 170(1-2):65-72. PubMed ID: 24529790
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regulated delayed synthesis of lipopolysaccharide and enterobacterial common antigen of Salmonella Typhimurium enhances immunogenicity and cross-protective efficacy against heterologous Salmonella challenge.
    Huang C; Liu Q; Luo Y; Li P; Liu Q; Kong Q
    Vaccine; 2016 Aug; 34(36):4285-92. PubMed ID: 27423383
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization and Protective Efficacy of Type III Secretion Proteins as a Broadly Protective Subunit Vaccine against Salmonella enterica Serotypes.
    Martinez-Becerra FJ; Kumar P; Vishwakarma V; Kim JH; Arizmendi O; Middaugh CR; Picking WD; Picking WL
    Infect Immun; 2018 Mar; 86(3):. PubMed ID: 29311233
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.